Evidence map›Paper›PMID 24928536›Full record

ArticleNeuromuscular disorders : NMD2014

Conserved regions of the DMD 3' UTR regulate translation and mRNA abundance in cultured myotubes.

C Aaron Larsen, Michael T Howard

Open access · greenAbstract read
In one paragraph

Article in Neuromuscular disorders : NMD, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. When SizeBiomedicines · 2023
    Article
  3. Variations inGenes · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

C Aaron LarsenDepartment of Human Genetics, University of Utah, Salt Lake City, UT, United States.
Michael T HowardDepartment of Human Genetics, University of Utah, Salt Lake City, UT, United States. Electronic address: mhoward@genetics.utah.edu.
University of Utah · US

Funding

Evaluating the efficiency and specificity of stop codon suppression therapyR21NS083884 · NINDS · UNIVERSITY OF UTAH · PI HOWARD, MICHAEL T · 2013 to 2014
$408k
NINDS NIH HHS NS083884NINDS NIH HHS R21 NS083884
6 · The paper itself

Abstract

Duchenne muscular dystrophy (DMD), a severe muscle-wasting disease, is caused by mutations in the DMD gene, which encodes for the protein dystrophin. Its regulation is of therapeutic interest as even small changes in expression of functional dystrophin can significantly impact the severity of DMD. While tissue-specific distribution and transcriptional regulation of several DMD mRNA isoforms has been well characterized, the post-transcriptional regulation of dystrophin synthesis is not well understood. Here, we utilize qRTPCR and a quantitative dual-luciferase reporter assay to examine the effects of isoform specific DMD 5' UTRs and the highly conserved DMD 3' UTR on mRNA abundance and translational control of gene expression in C2C12 cells. The 5' UTRs were shown to initiate translation with low efficiency in both myoblasts and myotubes. Whereas, two large highly conserved elements in the 3' UTR, which overlap the previously described Lemaire A and D regions, increase mRNA levels and enhance translation upon differentiation of myoblasts into myotubes. The results presented here implicate an important role for DMD UTRs in dystrophin expression and delineate the cis-acting elements required for the myotube-specific regulation of steady-state mRNA levels and translational enhancer activity found in the DMD 3' UTR.

Indexed as

3' Untranslated RegionsAnimalsCell LineConserved SequenceDystrophinGene Expression RegulationMiceMuscle DevelopmentMuscle Fibers, SkeletalMyoblastsProtein BiosynthesisProtein IsoformsReverse Transcriptase Polymerase Chain ReactionRNA, Messenger3' Untranslated RegionsDMD protein, humanDystrophinProtein IsoformsRNA, Messenger3′ UTR5′ UTRDMDDuchenne muscular dystrophyTranslational control

Identifiers

PMID24928536
PMCPMC4114305
OpenAlexW2065980863

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.